Mitochondrial Replacement Techniques Are ‘Ethically Permissible’ and Worthy of Clinical Study, US Panel Advises

Three researchers were brought together by the Institute of Medicine (IOM) to consider the ethics, guidelines, and potential risks of mitochondrial replacement techniques (MRTs) aiming to prevent mother-to-child transmission of mitochondrial diseases. Their article, “Mitochondrial Replacement Techniques — Implications for the Clinical Community,” was published in The New England Journal of Medicine.

IOM Report on Mitochondrial Replacement Therapy Welcomed by NY Stem Cell Group

The New York Stem Cell Foundation (NYSCF), an independent organization founded in 2005 to accelerate stem cell research into possible disease cures and better treatments, applauded the National Academies of Sciences, Engineering, and Medicine’s Institute of Medicine (IOM) report upholding the use of mitochondrial replacement therapy (MRT) on ethical grounds, provided certain conditions…